We can work with you on the selection and use of medical imaging and digital biomarkers for your drug development programs, directly and as part of collaborative consortia.
We are experts in the definition and delivery of early phase clinical development, where rigorous patient safety runs hand-in-hand with flexibility around trial design and data analytics.
Our global network of over 2,000 imaging centers across 75 countries ensures large-scale trials can be set up quickly and efficiently, while our custom TrialTracker platform delivers highly reliable, regulatory compliant data.
We understand the challenges of extended longitudinal studies. We support you to monitor patient safety and drug utilization for ongoing optimization of patient pathways post-marketing.
Sign up below and we'll send you the latest insight, knowledge and innovations from IXICO to your inbox.
Subscribe to content